Drug Sponsors

Amgen to acquire Onyx Pharmaceuticals

Monday, August 26, 2013 12:07 PM

Amgen will acquire San Francisco, Calif.-based Onyx Pharmaceuticals, purchasing all of the outstanding shares of Onyx for $125 per share in cash, for a total purchase price of $10.4 billion, or $9.7 billion net of estimated Onyx cash. The boards of both companies have approved the transaction.

More... »

WIRB Copernicus Group

Nuvilex restructures for biotechnology focus

Friday, August 23, 2013 12:36 PM

Nuvilex, an international biotechnology company and former provider of natural products, as well as cell and gene therapy solutions for the treatment of diseases, has restructured corporate operations in an effort to focus on its biotechnology core businesses.

More... »

Takeda expands to Peru

Friday, August 23, 2013 12:22 PM

Zurich-based Takeda Pharmaceuticals International has further expanded its presence in Latin America with the launch of a wholly-owned subsidiary in Peru. Takeda Peru S.R.L. will be headquartered in Lima and will be responsible for the sales and marketing of Takeda's products in Peru.

More... »

Vical restructures, 39% staff reduction

Friday, August 23, 2013 12:15 PM

Vical, which researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases, has announced a restructuring to conserve capital, including a staff reduction of 47 employees, approximately 39% of the company's total workforce. Following the restructuring, the company will have approximately 74 employees. In addition, the company is focusing its resources on its infectious disease vaccine programs and terminating activities related to Allovectin, the company's investigational cancer immunotherapy which recently failed to meet its phase III efficacy endpoints.

More... »

Litera acquires AxxiTRIALS Clinical Trials Portal

Wednesday, August 21, 2013 10:30 AM

Litera has acquired AxxiTRIALS, a Clinical Trials Portal solution providing life science companies and CROs with a platform designed to speed site startup, patient recruitment and end-to-end clinical trial operations.

More... »

Abbott acquires OptiMedica

Monday, August 19, 2013 02:10 PM

Abbott has acquired OptiMedica, a privately-held, Silicon Valley-based ophthalmic device company.

More... »

STADA acquires Thornton & Ross

Monday, August 19, 2013 09:07 AM

Pharmaceutical company Stada Arzneimittel has purchased Thornton & Ross, a British prescription-free OTC manufacturer, after Stada and the owners had already announced exclusive contract negotiations Aug. 6.

More... »

Boehringer Ingelheim Chemicals to close Virginia facility

Friday, August 16, 2013 01:49 PM

Boehringer Ingelheim Chemicals will close its Petersburg, Va. plant at the end of 2014. The facility will continue normal operations through the remainder of 2013 and phase out operations the following year. The closure will impact 240 employees through a multi-stage process beginning December.

More... »

Arcturus Therapeutics acquires UNA patent estate from Marina Biotech

Friday, August 16, 2013 12:10 PM

Arcturus Therapeutics, which focuses on RNA interference (RNAi) technologies for the treatment of disease, has acquired the patented portfolio of Unlocked Nucleobase Analog (UNA) intellectual property from Marina Biotech. Financial terms of the UNA agreement were not disclosed.

More... »

Quintiles to acquire Novella Clinical

Wednesday, August 14, 2013 01:22 PM

CRO Quintileshas signed an agreement to acquire Novella Clinical, a full-service CRO focused primarily on emerging oncology customers as well as those in the medical device and diagnostics sectors. 

More... »

Subscribe to The CenterWatch Monthly



Browse by:


August 18

Ebola outbreak highlights need to improve biosafety, infrastructure to handle future health emergencies

More African American professional women open to participating in medical research

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs